Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, PET, FVT

Kindred Biosciences to Participate in the Oppenheimer & Co. Specialty Pharmaceuticals Conference



SAN FRANCISCO, Oct. 5, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that Denise Bevers, Co-Founder and Chief Operating Officer, will participate in the Oppenheimer & Co. Specialty Pharmaceuticals Conference, being held on October 11, 2017 in New York City. The event will feature one-on-one meetings at which investors will have the opportunity to meet with management to discuss key therapeutic programs in development and upcoming milestones.

Kindred Biosciences, Inc. Logo

About Kindred Biosciences 

Kindred Biosciences is a pre-commercialization stage biopharmaceutical company focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats and horses. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.

For more information or to download the corporate presentation, visit www.KindredBio.com/LearnMore. Stay connected with KindredBio on Facebook at www.Facebook.com/KindredBio.

Contact

Russell Radefeld
KindredBio
russell.radefeld@kindredbio.com 
(650) 701-7904

 

SOURCE Kindred Biosciences, Inc.


These press releases may also interest you

at 17:00
Open Access publishing is gaining popularity as the world is increasingly connected online today, facilitating archiving, indexing, data mining, retrieving, and speedy distribution of researched information. Open access publishing is producing a...

at 17:00
A new global study from SMART Technologies, the world leader in education technology, gives insight into how a school's approach to planning, implementing and using technology can impact teaching and learning outcomes. Released today, the study...

at 17:00
Renovatm Therapeutics, a biotechnology company developing gene and peptide-based treatments for cardiovascular and metabolic diseases, announced today that an abstract of a study in a preclinical model of type 1 diabetes was accepted as a...

at 12:00
ATLANTA, June 24, 2018 /PRNewswire-PRWeb/ -- OxBlue launched a new interface designed to provide construction industry professionals with a more intuitive and thoughtful experience. The innovative technology creates an effortless experience for...

at 11:57
IEEE, the world's largest technical professional organization dedicated to advancing technology for humanity, today issued a statement that strong encryption is essential to protect individuals, businesses and governments from malicious cyber...

at 11:00
Lowestcarinsuranceratesonline.com has released a new blog post that explains how many car insurance quotes should be obtained and analyzed before signing a deal. Car insurance quotes are price estimates, based on the info provided by the client....




News published on 5 october 2017 at 16:01 and distributed by: